RANDOMIZED PHASE II TRIAL OF LUTETIUM LU 177 DOTATATE VERSUS EVEROLIMUS IN SOMATOSTATIN RECEPTOR POSITIVE BRONCHIAL NEUROENDOCRINE TUMORS
ENROLLING
Trial ID:
NCT04665739 Protocol # :
22-649
Phase
II
Disease Sites
Neuroendocrine/Carcinoid
Principal Investigator
Chan, Jennifer, Ang
Site Research Nurses
Connelly, Alexandra
Graham, Christopher
Ritterband, Lauren
Sawin, Mark
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-649
22-649